Ghosh Suvranil, Hazra Joyita, Pal Koustav, Nelson Vinod K, Pal Mahadeb
Division of Molecular Medicine, Bose Institute, Kolkata, West Bengal, India.
Department of Biotechnology, Indian Institute of Technology Madras, Tamil Nadu, India.
Curr Res Pharmacol Drug Discov. 2021 Jul 8;2:100034. doi: 10.1016/j.crphar.2021.100034. eCollection 2021.
Prostate cancer (PCa) is a major cause of morbidity and mortality in men worldwide. A geographic variation on the burden of the disease suggested that the environment, genetic makeup, lifestyle, and food habits modulate one's susceptibility to the disease. Although it has been generally thought to be an older age disease, and awareness and timely execution of screening programs have managed to contain the disease in the older population over the last decades, the incidence is still increasing in the population younger than 50. Existing treatment is efficient for PCa that is localized and responsive to androgen. However, the androgen resistant and metastatic PCa are challenging to treat. Conventional radiation and chemotherapies are associated with severe side effects in addition to being exorbitantly expensive. Many isolated phytochemicals and extracts of plants used in traditional medicine are known for their safety and diverse healing properties, including many with varying levels of anti-PCa activities. Many of the phytochemicals discussed here, as shown by many laboratories, inhibit tumor cell growth and proliferation by interfering with the components in the pathways responsible for the enhanced proliferation, metabolism, angiogenesis, invasion, and metastasis in the prostate cells while upregulating the mechanisms of cell death and cell cycle arrest. Notably, many of these agents simultaneously target multiple cellular pathways. We analyzed the available literature and provided an update on this issue in this review article.
前列腺癌(PCa)是全球男性发病和死亡的主要原因。该疾病负担的地理差异表明,环境、基因构成、生活方式和饮食习惯会调节一个人对该疾病的易感性。尽管人们普遍认为这是一种老年疾病,并且在过去几十年中,筛查项目的普及和及时实施成功控制了老年人群中的该疾病,但在50岁以下人群中,其发病率仍在上升。现有的治疗方法对局限性且对雄激素敏感的前列腺癌有效。然而,雄激素抵抗性和转移性前列腺癌的治疗具有挑战性。传统的放疗和化疗不仅费用高昂,还会带来严重的副作用。许多传统医学中使用的植物分离出的植物化学物质和提取物因其安全性和多种治疗特性而闻名,其中许多具有不同程度的抗前列腺癌活性。正如许多实验室所表明的,本文讨论的许多植物化学物质通过干扰前列腺细胞中负责增强增殖、代谢、血管生成侵袭和转移途径的成分,同时上调细胞死亡和细胞周期停滞的机制,来抑制肿瘤细胞的生长和增殖。值得注意的是,这些药物中的许多同时针对多个细胞途径。在这篇综述文章中,我们分析了现有文献并提供了关于这个问题的最新情况。